• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Gegen Qinlian decoction enhances immunity and protects intestinal barrier function in colorectal cancer patients via gut microbiota

    2021-01-15 08:58:14YangLiZhongXinLiChenYangXieJingFanJiLvXinJianXuJianLvWenTaoKuaiYiTaoJia
    World Journal of Gastroenterology 2020年48期

    Yang Li, Zhong-Xin Li, Chen-Yang Xie, Jing Fan, Ji Lv, Xin-Jian Xu, .Jian Lv, Wen-Tao Kuai, Yi-Tao Jia

    Abstract

    Key Words: Colorectal cancer; Gegen Qinlian decoction; Immunity; Inflammation; Intestinal barrier function; Gut microbiota

    INTRODUCTION

    Colorectal cancer (CRC) is the third most common cancer worldwide[1]. Economic and social development and changes in lifestyle in China have resulted in a rapid increase in the incidence of CRC. At present, the main treatments for CRC are surgery, radiotherapy and chemotherapy, but the overall effect is not satisfactory. With the advent of immune checkpoint inhibitors, there is a new dawn in the treatment of malignant tumors such as melanoma[2]. However, the therapeutic effect of immune checkpoint inhibitors in CRC is not optimistic. The reason for this is that the tumor microenvironment is closely related to the effect of CRC treatment[3,4]. Based on the particular anatomy, the microenvironment of CRC is composed of intestinal microorganisms, their metabolites or secretions, and the intestinal barrier.

    It has been shown that the number of immune cells in patients with CRC is important for prognosis[5]. There must be sufficient immune cell infiltration in the tumor to ensure the killing effect. The proportion of T and natural killer (NK) cells in peripheral blood of CRC patients decreases, while the proportion of regulatory T (Treg) cells increases significantly, and the percentage of NKT cells is independently correlated with disease-free survival[6]. It has been found that cytokines such as interferon (IFN)-γ and interleukin (IL)-2 can improve the therapeutic effect of CRC by recruiting lymphocytes[7,8]. In addition, the increase in tumor necrosis factor (TNF)-α can promote the occurrence of chronic inflammation, but the inhibition of immune cells can be eliminated by blocking the signal transduction function of TNF-related receptors in T cells. In recent years, it has been found that serotonin (5-hydroxytryptamine, 5-HT) is not only known to regulate intestinal movement and secretion, but is also an important immunomodulator[9,10]. However, the relationship between 5-HT and poor prognosis, metastasis and recurrence of CRC is still controversial[11].

    The tight junction components are composed of occludin, zonula occludens (ZO)-1, ZO-2, ZO-3, claudin and junction adhesion molecules. The decreased expression of ZO-1 is related to cancer invasion[12]. The intestinal barrier function of patients with CRC is destroyed by decreased expression of ZO-1 and occludin[13]. The expression of ZO-1 and occludin is also decreased in inflammatory bowel diseases, while the level of nuclear factor (NF)-κB, TNF-α and IL-1 is significantly increased[14]. Evidence suggests that proinflammatory factor TNF-α can induce tumor invasion and metastasis by reducing the expression of E-cadherin and ZO-1[15].

    The uniqueness of CRC suggests that its occurrence and development, and destruction of the intestinal barrier may be inseparable from gut microbiota. There are approximately 1000 species of bacteria in the human intestinal system, more than 10 times the number of human eukaryotic cells[16]. If intestinal diseases do not take into account the role of bacteria, it is difficult to know the real cause of the disease. Recent studies have shown that changes in the type and number of gut microbiota play an important role in the occurrence and development of CRC[17]. It has been found that the combined action ofEscherichia coliandBacteroides fragiliscan promote the occurrence of CRC[18]. One study found that familial adenomatous polyposis eventually becomes cancerous due to the formation of bacterial biofilms that are mainly composed of the above two bacteria[19]. Other studies have also found thatBacteroides fragilis(B. fragilis) can activate the NF-κB pathway, leading to inflammation and ultimately carcinogenesis[20]. Yachidaet al[21]showed that the decreased abundance ofPrevotellaand increased abundance ofMegamonaswere significantly associated with progression of CRC. The Gustave Roussy Cancer Campus in France found that the increase in the relative abundance ofAkkermansia muciniphilacan promote the infiltration of immune cells into tumor tissues, which in turn improves the efficacy of immune checkpoint inhibitors[22-25]. The increase in harmful bacteria can inhibit the expression of mucin, thus weakening the protective effect of the intestinal barrier, which increases damage to the intestinal epithelium by intestinal toxic substances.

    Regulation of gut microbiota is expected to become an adjuvant therapy for CRC. Traditional Chinese medicine has unique advantages in this respect. According to traditional Chinese medicine, CRC originates from the damp-heat syndrome, which is roughly similar to the imbalance of gut microbiota in western medicine. Gegen Qinlian decoction (GQD) is a classical traditional Chinese medicine for the treatment of dampheat syndrome, which has a history of more than 2000 years. The formula contains four types of medicinal materials: Radix Puerariae, Radix Scutellariae, Rhizoma Coptidis and Radix Glycyrrhizae. GQD can be used in the treatment of type 2 diabetes and ulcerative colitis (UC)[26,27]. In our previous study, using the Traditional Chinese Medicine System Pharmacology Database, we found that GQD had a direct antitumor effect, and was combined with programmed cell death protein (PD)-1 inhibitors to treat microsatellite stable (MSS) tumor-bearing mice, which synergistically enhanced anti-PD-1 immunotherapy[28].

    However, the effect of GQD on intestinal mucosal barrier function and gut microbiota in patients with CRC has not been reported. In this study, based on previous animal studies, we determined the changes in immune cells, cytokines and intestinal barrier function in patients with CRC after GQD administration to assess the therapeutic mechanism of GQD in improving immune function, reducing inflammation and protecting intestinal barrier function.

    MATERIALS AND METHODS

    GQD preparation

    The herbal formula GQD is a combination of four medicinal herbs: Radix Puerariae (15 g), Scutellariae Radix (9 g), Coptidis Rhizoma (9 g), and liquorice (6 g) at a ratio of 5:3:3:2 (w/w/w/w). GQD was prepared at the pharmacy of the Fourth Hospital of Hebei Medical University, and was identified by two experienced pharmacists.

    Patient variables and medication standard

    Seventy patients with colon or rectal cancer diagnosed for the first time in the Fourth Hospital of Hebei Medical University were selected. Diagnosis and tumor-nodemetastasis (TNM) classification were made according to the Seventh Edition of TNM classification criteria issued by the Union for International Cancer Control (UICC). On admission, the patients were randomly divided into the control group (n= 37) and the treatment group (n= 33). The study was approved by the Ethics Committee of the Fourth Hospital of Hebei Medical University and followed the ethical standards stipulated in the Declaration of Helsinki. All patients gave informed consent. The control group received routine treatment and elective surgery after admission. The treatment group received routine treatment and oral GQD for 7 d (250 mL, twice daily) before surgery. The subjective and abdominal symptoms of the patients were observed and recorded.

    Flow cytometry

    Peripheral blood was collected at the beginning of the study in the control group, and was collected in the treatment group before and after medication. All peripheral blood was collected from veins with EDTA-Li micro-anticoagulant tubes. Blood was stained with anti-human CD45-FITC (REFA07749), anti-human CD3-PC5, anti-human CD4-RD1, anti-human CD8-ECD, anti-human CD(16+56)-PE (A07735), anti-human CD4-FITC (REFA07750), anti-human CD25-PE (REFA07774) and anti-human CD127-PC5 (REFA64617) (Beckman Coulter, CA, United States), which was divided into three tubes for testing. Measurement was carried out on a Fortessa Flow Cytometer (BD, San Jose, CA, United States). Analysis was performed with Flow Jo version 10 (Tree Star Inc., Ashland, OR, United States).

    Enzyme-linked immunosorbent assay

    Peripheral blood was collected at the beginning of the study in the control group, and was collected before and after medication in the treatment group. All sera were obtained by centrifugation and stored at -80°C. Commercially available enzyme-linked immunosorbent assay (ELISA) kits (ABclonal Biotechnology, Wuhan, China) were used to detect the levels of TNF-α, IFN-γ, IL-2, IL-6 and IL-10 in the serum of patients with CRC. 5-HT was detected using another ELISA kit (GeneTex, Hsinchu City, Taiwan).

    Immunohistochemistry

    Tumor and normal tissues in the control group and treatment group were removed after surgery. The colon and rectum specimens were harvested and embedded in paraffin blocks and cut into 4-μm-thick tissue sections. The morphological changes in normal tissues were confirmed by hematoxylin and eosin staining. For immunohistochemical staining, the paraffin-embedded slides were dewaxed using xylene and rehydrated using alcohol of graded concentrations. Endogenous peroxidase activity was eliminated by 3% H2O2for 15 min. The slides were then blocked with 5% goat serum for 20 min at 37°C, followed by primary antibody incubation overnight at 4°C. The next day, each sample was incubated with horseradish-peroxidase-labeled secondary antibody for 1 h at room temperature, followed by staining with the ready-to-use reagent DAB kit (ZSGB-BIO, Beijing, China). After dehydration and drying, the tissue sections were mounted with neutral gum and observed under a microscope (Olympus, Tokyo, Japan). Three high power visual fields were randomly selected for image acquisition, and image quantitative analysis was carried out with Image-Pro Plus 6.0 software. The average optical density of each protein was finally expressed by IOD value.

    Analysis of fecal 16S rDNA

    Feces were collected from the treatment group before and after medication for gut microbiota analyses by 16S rDNA. Microbial genomic DNA was extracted from fecal samples using a QIAamp DNA Stool Mini Kit (MoBio Laboratories Inc., Carlsbad, CA, United States). The 16S rDNA V4 region was amplified using the 515F primers (515FGTGCCAGCMGCCGCGGTAA) and 806R primers (GGACTACHVGGGTWTCTAAT). PCR product quantification, qualification and purification were performed. Library preparation and sequencing were performed on the MiSeq platform (Beijing Genomics Institute, Shenzhen, China). The 16S rDNA sequencing data were quality filtered using FLASH (Fast Length Adjustment of Short reads, version 1.2.11). Operational taxonomic units (OTUs) were picked at a 97% sequence similarity cut-off, and the identified taxonomy was then aligned using Silva (Release128 http://www.arbsilva.de). The RDP classifier (version 2.2) was used to classify OTUs at a given taxonomic rank.

    Statistical analysis

    Statistical analysis was performed using SPSS 21.0 software (Chicago, IL, United States). Measurement data are expressed as mean ± standard deviation. Comparisons between two groups were assessed using Student’s unpairedttests. The Student’s pairedttest was used to compare the results between pre-treatment and posttreatment. If it did not conform to the normality test, the rank sum test was used.P< 0.05 was selected as the point of minimal statistical significance in every comparison.

    RESULTS

    Comparison of clinical data between the control and treatment groups

    We compared clinical data between the control group and treatment group, including sex, age, tumor location, T stage, lymph node, and TNM stage (Table 1). The results showed that the clinical data of the two groups were consistent.

    Safety evaluation of GQD

    In the treatment group, nine patients had abdominal pain and distension, and 14 had diarrhea. Twelve patients complained of tenesmus. Following the administration of GQD, 12 of these 14 patients stated that their abdominal symptoms were better than those before treatment, including alleviation of diarrhea and reduced defecation, from five to three times per day. Another seven patients stated that the symptoms of tenesmus improved after taking GQD. No related adverse events were observed (Table 2).

    GQD enhanced immunity

    To determine the effect of GQD on immune function in patients with CRC, we measured immune cells in the control and treatment groups. There was no difference in the proportion of peripheral immune cells, including CD4+T cells, CD8+T cells, NK cells (CD3-CD16+CD56+), NKT cells (CD3+CD16+CD56+) and Treg cells (CD4+CD25+CD127dim) between the control and pre-treatment group (P> 0.05) (Figure 1). However, compared with the control group and pre-treatment group, the proportion of CD4+T cells was significantly increased in the post-treatment group (P< 0.05) (Figure 1A and B). There was no significant difference in CD8+T cells and NK cells among the three groups (P> 0.05) (Figure 1C-F). The proportion of NKT cells in the control group and pre-treatment group was 1.28% and 1.58%, respectively, and increased to 2.58% in the post-treatment group (P< 0.05) (Figure 1E and H). There was almost no difference in the proportion of Treg cells among the three groups (P> 0.05) (Figure 1G and I).

    GQD reduced inflammation

    To establish whether GQD reduced inflammation in patients with CRC, serum cytokine levels were measured with ELISA. The level of TNF-α in the post-treatment group was significantly lower than that in the control and pre-treatment groups. The average value of TNF-α in the control and pre-treatment groups was 12.85 pg/mL and 12.47 pg/mL, respectively, and the average value in the post-treatment group was 9.88 pg/mL (P< 0.05) (Figure 2A). The levels of other cytokines including IFN-γ, IL-2, IL-6 and IL-10 did not change significantly among the three groups (P> 0.05) (Figure 2B-E). In addition, compared with the pre-treatment group, GQD significantly reduced the level of 5-HT in the post-treatment group (P< 0.05). Although the level of 5-HT was also lower than that in the control group, it did not reach statistical significance (Figure 2F).

    GQD enhanced intestinal barrier function

    In the normal tissues of patients with CRC, the inflammatory reaction in the control group was more severe than that in the treatment group, in terms of the distribution of lymph nodes and destruction of intestinal mucosa (Figure 3A and B). To detect the effect of GQD on intestinal barrier function in patients with CRC, the expression of ZO-1, occludin, NF-κB and TNF-α in tumor and normal tissues was detected byimmunohistochemistry (Figure 4A). The expression of ZO-1 in tumor and normal tissues in the treatment group was significantly higher than that in the control group (P< 0.05) (Figure 4B). The expression of occludin in tumor tissues in the treatment group was significantly higher than that in the control group (P< 0.05), but there was no change in normal tissues between the control and treatment groups (P> 0.05) (Figure 4C). Similarly, compared with the control group, expression of NF-κB and TNF-α in tumor tissues of the treatment group was significantly reduced (P< 0.05) (Figure 4D and E). There was also no significant change in normal tissues between the control group and treatment group (P> 0.05) (Figure 4D and E). GQD prevented destruction of the intestinal barrier in patients with CRC.

    Table 1 Clinical data of patients with colorectal cancer in the two groups

    Table 2 Safety evaluation in patients with colorectal cancer in the treatment group

    GQD regulated the gut microbiota

    To determine the influence of GQD on the gut microbiota, 16S rDNA was used to detect the changes before and after treatment. Under 97% similarity, the number of OTUs in each sample was obtained. A Venn diagram showed 143 different species between the pre-treatment and post-treatment groups (Figure 5A). Partial least squares discriminant analysis demonstrated a notable clustering effect in the gut microbiota pre-treatment and post-treatment (Figure 5B). By visualizing the landscape of the gut microbiota in all feces samples, we found that the alpha and beta diversity of the gut microbiota was significantly lower in the post-treatment group than in the pretreatment group based on Ace, Chao and Shannon indices (Figure 5C and D).

    Figure 1 Gegen Qinlian decoction enhanced the immunity. A, C, E and G: Flow cytometry analysis of the proportions of CD4+T, CD8+T, natural killer (NK), NKT and Treg cells in the control group, the pre-treatment group and the post-treatment group of patients with colorectal cancer; B, D, F, H and I: Changes in the proportions of CD4+T, CD8+T, NK, NKT and Treg cells (aP < 0.05).

    We analyzed the gut microbiota for differences between the pre-treatment and posttreatment groups. Four dominant phyla were identified. Compared with pretreatment, the abundance of Bacteroidetes was increased, while the abundance of Firmicutes, Proteobacteria and Verrucomicrobia was decreased post-treatment (Figure 5E). When we compared the phylogenetic composition of common bacterial taxa at the genus level, we found thatBacteroides,AkkermansiaandPrevotellawere enriched and the abundance ofMegamonasandVeillonellawas decreased in the posttreatment group (Figure 5F and G).

    Figure 2 Gegen Qinlian decoction reduced inflammation. A-E: Changes in the concentration of cytokines [including tumor necrosis factor-α, interferon-γ, interleukin (IL)-2, IL-6, and IL-10] in serum among the control group, pre-treatment group and post-treatment group of patients with colorectal cancer (aP < 0.05); F: Changes in neurotransmitter 5-HT levels in serum among the three groups (aP < 0.05). TNF-α: Tumor necrosis factor-α; IFN-γ: Interferon-γ; IL: Interleukin; 5-HT: 5-Hydroxytryptamine.

    Figure 3 The morphological features of normal tissues in the control and treatment groups by HE staining (× 100 magnification). A: The control group; B: The treatment group.

    To analyze these findings further, the differential genes of gut microbiota between the two groups were enriched by KEGG function. We found functional differences in the gut microbiota between the pre-treatment and post-treatment groups, which included energy metabolism, immune system, nervous system and cancer (P< 0.05) (Figure 6). We suggest that GQD changed the functional state of patients with CRCviathe gut microbiota.

    Figure 4 Gegen Qinlian decoction enhanced intestinal barrier function. A: The expression of zonula occludens (ZO)-1, occludin, nuclear factor (NF)-κB and tumor necrosis factor (TNF)-α in tumor and normal tissues between the control and treatment groups determined by immunohistochemistry (× 400 magnification); B-E: Histogram showing the expression of ZO-1, occludin, NF-κB and TNF-α (aP < 0.05). ZO-1: Zonula occludens-1; NF-κB: Nuclear factor-κB; TNF-α: Tumor necrosis factor-α.

    DISCUSSION

    GQD is composed of Radix Puerariae, Radix Scutellariae, Rhizoma Coptidis and Radix Glycyrrhizae, the heat-clearing and detoxifying effects of which are well known. Wanget al[29]reported that GQD combined with other traditional Chinese medicine can prolong progression-free survival of patients with cholangiocarcinoma, and they also found that GQD restricts tumor growth in patients with CRC, but did not clarify the mechanism. In our study, we analyzed the immune status of peripheral blood and found that GQD increased the number of CD4+T cells and NKT cells; both of which contribute to the immune response against tumor cells. NKT cells are a group of special T cells with both T cell and NK cell receptors. Although the number is small, it can produce a large number of cytokines, but also reflects the state of immune metabolites, and can fight tumor cells together with CD4+T cells. Mossanenet al[30]found that CD4+T cells and NKT cells can work together against tumor cells. It has been shown that the decrease in the proportion of NK and NKT cells and the increase in the proportion of Treg cells in patients with CRC lead to poor efficacy of comprehensive treatment[31]. GQD regulates immune balance by inhibiting the differentiation of Treg cells in mice with influenza[32]. In this study, GQD had no significant effect on NK and Treg cells in peripheral blood, which may be related to the small sample size and activation state. Even though the proportion of NK and Treg cells in lymphocytes does not change significantly, their activation state may be changed. Future studies will increase the sample size and measure the activation state of immune cells to explore the effect of GQD on immune function.

    Chronic inflammation is one of the main risk factors for CRC. Patients with inflammatory bowel diseases, including UC and Crohn’s disease, have a higher risk of CRC than the general population[33,34]. Recently, it was reported that GQD has antiinflammatory and anti-infective effects. A variety of active components of GQD, such as baicalin, licorice flavonoids and berberine, can significantly reduce inflammation and oxidative stress. GQD also decreases diarrhea in piglets by reducing the levels of TNF-α and IL-6[35]. Wuet al[36]found that GQD extract could resist the increase in cytokines IL-1β, cyclo-oxygenase-2, intercellular adhesion molecule-1 and TNF-α induced by irinotecan, indicating that GQD has anti-inflammatory effects. In addition, TNF-α is an important inflammatory factor, which can significantly promote tumor progression. We found that GQD decreased the level of TNF-α, which verified that GQD could also reduce the inflammatory response in patients with CRC.

    Studies have shown that 5-HT is obviously associated with diarrhea[37]. GQD was originally used to treat diarrhea. The main components of GQD, such as puerarin and berberine, reduce secretion of 5-HT[38,39]. In addition, berberine improves visceral hypersensitivity in rats with diarrhea and irritable bowel syndrome by reducing the levels of 5-HT, substance P and calcitonin gene peptide. We found that the level of 5-HT in patients with CRC after taking GQD was significantly lower than before treatment. We speculate that the reduction of diarrhea in most patients with CRC may be closely related to a decrease in 5-HT by GQD.

    Figure 5 Gegen Qinlian decoction regulated the gut microbiota. A: Venn diagram of the total number of species shared between the pre-treatment and post-treatment groups; B: Principal coordinate analysis at the operational taxonomic unit level; C and D: Alpha diversity and beta diversity of the gut microbiota in the pre-treatment and post-treatment groups; E and F: Cumulative column chart of relative species abundance at the phylum and genus levels in the gut microbiome between the pre-treatment and post-treatment groups; G: Heatmap showing the changes in gut microbiota at the genus level between the pre-treatment and posttreatment groups. Columns represent samples and rows represent species. OUT: Operational taxonomic unit; PLS-DA: Principal coordinate analysis.

    The intestinal barrier can prevent harmful substances from entering the blood, thus avoiding a series of pathophysiological changes. It was found that the intestinal barrier function in patients with CRC was damaged, which was manifested by the decrease in intestinal tight junction proteins (ZO-1 and occludin)[40,41]. In addition, expression of ZO-1 and occludin in cancer tissues was significantly lower than that in paracancerous tissues in a colon cancer model induced by dextran sulfate sodium, suggesting that the intestinal barrier function of cancer tissue was destroyed, which eventually led to tumor progression, while the occurrence and development of colon tumor was significantly inhibited after restoration of intestinal barrier function[40]. Baicalin and puerarin, the main components of GQD, can reverse the epithelial–mesenchymal transition process of hepatocytes by upregulating the expression of ZO-1, occludin and claudin[42]. In our study, the expression of ZO-1 and occludin in CRC tissues after GQD administration was significantly higher than that in the control group. GQD also significantly promoted the expression of ZO-1 in normal tissues, while the expression of occludin in normal tissues was higher in both the control and treatment groups. These results suggest that GQD promotes the recovery of intestinal barrier function, which may be one of the reasons for the relief of diarrhea and other clinical symptoms.

    Figure 6 KEGG functional enrichment of differential genes in the gut microbiota of patients with colorectal cancer between the pretreatment and post-treatment groups.

    Inflammatory factors not only cause destruction of the intestinal barrier, but are also related to tumorigenesis. The decrease in TNF-α regulates intestinal epithelial permeability by upregulating the expression of ZO-1 and occludin proteins. It can increase the expression of adhesion molecules in endothelial cells and neutrophils, thus reducing the inflammation caused by migration, finally delaying tumor occurrence. In our study, consistent with the results of inflammatory factors in the peripheral blood, the expression of TNF-α and NF-κB in CRC tissues in the treatment group, which is significantly related to inflammation, was significantly lower than that in the control group. Although expression of TNF-α and NF-κB in the normal tissues of the treatment group was not significantly different from that of the control group, there was a decreasing trend. Therefore, we believe that GQD may upregulate intestinal tight junction proteins in the tumor microenvironment, improve intestinal inflammation, and protect the integrity of the intestinal barrier function, thus relieving clinical symptoms such as diarrhea in patients with CRC.

    Intestinal microecological disorders are closely related to the occurrence and development of CRC[43]. Because of its special location, the gut microbiota is an important part of the microenvironment of CRC. The abundance of harmful bacteria such asEscherichia coli,Bacteroides fragilisandFusobacterium nucleatumincreased, while the abundance of beneficial bacteria such asAkkermansiaandPrevotelladecreased. 16S rDNA sequencing was used to analyze the gut microbiota of feces from patients with CRC before and after GQD administration. Compared with pre-treatment, the abundance of Bacteroidetes was increased, while the abundance of Firmicutes, Proteobacteria and Verrucomicrobia was decreased post-treatment. The increase in Firmicutes and the decrease in Bacteroidetes have been proved to contribute to the development of cancer. At the genus level, the abundance ofBacteroides,AkkermansiaandPrevotellawas enriched and the abundance ofMegamonasandVeillonellawas decreased in the post-treatment group. It was reported that the abundance ofRuminococcusandPrevotellain the intestine of rats with CRC was significantly lower than that of healthy rats, which indirectly indicates that the abundance of these two bacteria is negatively related to the occurrence and development of CRC[44].Megamonascan promote the invasion and metastasis of CRC[18]. We demonstrated that GQD reduces harmful bacteria and increases beneficial bacteria, which is consistent with our previous animal experiments and literature reports, confirming that GQD may delay the development of CRC by regulating gut microbiota.

    Many scientists have found that the role of gut microbiota is not only limited to the intestinal tract, but also has an important impact on the normal function of the immune system[45]. A clinical study found that the abundance ofFusobacterium nucleatumin the intestine of CRC patients was inversely proportional to the density of CD3+T cells. This suggests that gut microbiota may be involved in immune regulation. It was reported thatAkkermansiaplays a vital role in intestinal homeostasis, and its abundance is also proportional to the effect of PD-1 inhibitors on CRC[23]. In addition, the abundance ofMegamonasis closely related to immune function and the inflammatory response. NKT cells play an important role in intestinal immunity, which can regulate immune cells, including NK cells, dendritic cells, CD4+T cells and CD8+T cells[46]. However, animal experiments have shown thatB. fragilisinhibits NKT cell activation through sphingolipids.

    The increase in short chain fatty acids (SCFAs), metabolites of gut microbiota, helps to reduce inflammation. Furthermore,Akkermansia,Butyricicoccus,ClostridiumandRuminococcusof the gut microbiota reduce the intestinal-related chronic inflammation by reducing IL-6, IL-22, IL-1β and TNF-α, and play an immunomodulatory role to inhibit tumorigenesis[47]. Liuet al[48]found that GQD can regulate the gut microbiota of animals with diarrhea and increase the relative abundance ofAkkermansia,BacteroidesandRuminococcus[35]. Researchers have shown that certain gut microbiota in human feces can increase the content of CD8+T cells, and metabolites of gut microbiota such as SCFA can reduce 5-HT[49,50]. Combined with these changes, we consider that GQD may reduce the level of 5-HT by regulating the gut microbiota, thereby improving diarrhea symptoms in patients with CRC.

    Our previous animal experiments showed that GQD increased the content of CD8+T cells and reduced the inflammatory response by increasing the Bacteroidales S24-7 group[28]. In this study, Bacteroidetes,PrevotellaandRuminococcusin the gut microbiota were significantly increased by GQD, while the abundance ofMegamonaswas significantly decreased. It is precisely these changes in the abundance of gut microbiota that enhance the immune function and reduce the inflammatory response of patients with CRC. Low-grade chronic inflammation and damage to the intestinal barrier function are not only related to the changes in intestinal microorganisms, but also to the occurrence and development of CRC. In this study, the abundance ofAkkermansiaof patients with CRC after GQD administration was increased. AlthoughAkkermansiause mucin as the source of energy, a large number of observations have confirmed thatAkkermansiahas a positive regulatory effect on the thickness of the gut mucous layer and integrity of the intestinal barrier[51].

    Puerarin, the main component of GQD, can increase the abundance ofAkkermansiato promote the expression of ZO-1 and occludin, thereby protecting the intestinal barrier function[52]. Activation of the LPS–TLR4–NF-κB pathway has been shown to be involved in inflammatory processes and malignant transformation[53]. SCFAs are present in metabolites ofBacteroidesandPrevotella. SCFAs (especially butyrate) protect the intestinal barrier function by increasing the expression of claudin-1, ZO-1 and mucin[54,55]. SCFAs can also reduce the expression of NF-κB and IL-18 to inhibit inflammation and regulate the intestinal microecology[56]. These studies show that the gut microbiota and its metabolites play a pivotal role in protecting the integrity of the intestinal tract. Although we did not detect the metabolites of gut microbiota, GQD increased the abundance ofBacteroides,PrevotellaandAkkermansia, which increase the expression of ZO-1 and occludin, inhibit the NF-κB inflammatory signaling pathway, and reduce the inflammatory factor TNF-α in blood and tumor tissues, thereby protecting the intestinal barrier function and inhibiting the development of intestinal inflammation.

    KEGG function is significantly enriched in the immune system, energy metabolism, nervous system, and cancer, which indicates that the gut microbiota remodeled by GQD is related to the above functions. Our research shows that GQD can increase the number of immune cells, especially CD4+T cells and NKT cells, reduce the inflammatory response, and protect the intestinal barrier function. The abovementioned effects of GQD are likely to be achieved by regulating the gut microbiota, and it has good clinical application prospects.

    CONCLUSION

    GQD improves intestinal barrier function by reducing the systemic inflammatory reaction and enhancing immune function in patients with CRC. These functions may be achieved through regulation of the gut microbiota.

    ARTICLE HIGHLIGHTS

    Research conclusions

    GQD enhances the immunity and protects intestinal barrier function in patients with CRC by regulating the composition of gut microbiota.

    Research perspectives

    GQD has good clinical application prospects.

    国产精品久久久人人做人人爽| 日本wwww免费看| 人妻一区二区av| 韩国高清视频一区二区三区| 色播在线永久视频| 搡老岳熟女国产| 久久久精品区二区三区| 日本av手机在线免费观看| 国产精品亚洲av一区麻豆 | 最近最新中文字幕免费大全7| 一区在线观看完整版| 老司机影院成人| 国产极品粉嫩免费观看在线| 日韩 亚洲 欧美在线| 天天躁夜夜躁狠狠躁躁| 在线观看www视频免费| 高清黄色对白视频在线免费看| 免费黄色在线免费观看| 免费在线观看黄色视频的| 国产探花极品一区二区| 久久国产亚洲av麻豆专区| 亚洲美女视频黄频| 亚洲国产毛片av蜜桃av| 天堂8中文在线网| 18禁国产床啪视频网站| 91精品伊人久久大香线蕉| 日韩一本色道免费dvd| 国产又色又爽无遮挡免| 欧美成人午夜精品| 18禁裸乳无遮挡动漫免费视频| 免费观看av网站的网址| 亚洲,欧美精品.| 欧美 日韩 精品 国产| 亚洲久久久国产精品| 97精品久久久久久久久久精品| 青青草视频在线视频观看| 亚洲欧美成人综合另类久久久| 中文字幕人妻丝袜制服| 免费看不卡的av| 黄色 视频免费看| 亚洲自偷自拍图片 自拍| 一个人免费看片子| 国产精品欧美亚洲77777| 中文天堂在线官网| 天天躁夜夜躁狠狠躁躁| 如日韩欧美国产精品一区二区三区| 亚洲av综合色区一区| 亚洲成国产人片在线观看| 国产男女超爽视频在线观看| 国产av一区二区精品久久| 九九爱精品视频在线观看| 男女午夜视频在线观看| 欧美成人午夜精品| 男男h啪啪无遮挡| 一级毛片我不卡| 丝袜在线中文字幕| 男女午夜视频在线观看| 亚洲在久久综合| 国产精品香港三级国产av潘金莲 | 国产av国产精品国产| 日本vs欧美在线观看视频| 日本午夜av视频| 99re6热这里在线精品视频| 久久久久久久久免费视频了| 精品国产一区二区久久| 麻豆av在线久日| 亚洲国产欧美日韩在线播放| 91精品伊人久久大香线蕉| 一本—道久久a久久精品蜜桃钙片| 日本色播在线视频| 久久人妻熟女aⅴ| 人人妻人人澡人人爽人人夜夜| 中文字幕人妻丝袜一区二区 | 成人亚洲欧美一区二区av| 一区二区日韩欧美中文字幕| 免费黄网站久久成人精品| 免费久久久久久久精品成人欧美视频| 久久久久视频综合| 最黄视频免费看| 你懂的网址亚洲精品在线观看| 亚洲精品久久成人aⅴ小说| 亚洲欧美中文字幕日韩二区| 777米奇影视久久| 人人妻人人澡人人看| 亚洲国产精品一区三区| 国产精品偷伦视频观看了| 波野结衣二区三区在线| 国产爽快片一区二区三区| 不卡av一区二区三区| 男女边吃奶边做爰视频| 亚洲精品久久久久久婷婷小说| 秋霞伦理黄片| 青青草视频在线视频观看| 久久精品亚洲av国产电影网| 波野结衣二区三区在线| 欧美变态另类bdsm刘玥| 九九爱精品视频在线观看| 伦理电影免费视频| 美女福利国产在线| 国产精品无大码| 伦理电影免费视频| 亚洲av男天堂| 亚洲精品,欧美精品| 日韩一区二区视频免费看| 久久精品国产a三级三级三级| 999精品在线视频| 日韩一区二区视频免费看| av女优亚洲男人天堂| 中文欧美无线码| 国产成人免费无遮挡视频| 最近中文字幕2019免费版| 熟女av电影| 国产精品一区二区在线不卡| 日韩电影二区| 欧美精品av麻豆av| 色网站视频免费| 十八禁高潮呻吟视频| 国产高清国产精品国产三级| 一本—道久久a久久精品蜜桃钙片| 五月开心婷婷网| 国产亚洲精品第一综合不卡| 免费久久久久久久精品成人欧美视频| 国产欧美亚洲国产| 日韩 欧美 亚洲 中文字幕| 悠悠久久av| 9191精品国产免费久久| a级毛片在线看网站| 欧美日韩综合久久久久久| 日韩,欧美,国产一区二区三区| 日韩一区二区视频免费看| 在线亚洲精品国产二区图片欧美| 日韩一区二区三区影片| 精品久久蜜臀av无| 久久精品人人爽人人爽视色| 精品亚洲成a人片在线观看| 欧美日韩av久久| 欧美日韩视频精品一区| 久久精品国产亚洲av高清一级| 成人午夜精彩视频在线观看| 波多野结衣av一区二区av| 亚洲成人一二三区av| 啦啦啦啦在线视频资源| 日韩 亚洲 欧美在线| 最近2019中文字幕mv第一页| 美女国产高潮福利片在线看| 美国免费a级毛片| 啦啦啦视频在线资源免费观看| 一区二区三区四区激情视频| 久久久久久久精品精品| 色视频在线一区二区三区| 久久人人爽av亚洲精品天堂| 中国国产av一级| 精品第一国产精品| 观看美女的网站| 人人澡人人妻人| 极品人妻少妇av视频| bbb黄色大片| 99热国产这里只有精品6| 一本色道久久久久久精品综合| 亚洲av男天堂| 久久99精品国语久久久| 久久久精品免费免费高清| 欧美变态另类bdsm刘玥| 国产精品久久久人人做人人爽| 乱人伦中国视频| 丝袜喷水一区| 日韩电影二区| av视频免费观看在线观看| 欧美黑人欧美精品刺激| 久久鲁丝午夜福利片| 亚洲成色77777| 性高湖久久久久久久久免费观看| 亚洲精品一二三| av有码第一页| 国产成人精品久久久久久| 欧美日韩综合久久久久久| 女人久久www免费人成看片| 五月开心婷婷网| 大陆偷拍与自拍| 欧美激情极品国产一区二区三区| 亚洲第一青青草原| 午夜福利一区二区在线看| 热99久久久久精品小说推荐| 一边摸一边抽搐一进一出视频| 人人妻人人添人人爽欧美一区卜| 国产97色在线日韩免费| 777米奇影视久久| 国产精品亚洲av一区麻豆 | 亚洲国产欧美网| 桃花免费在线播放| 少妇人妻 视频| 国产精品人妻久久久影院| 天天躁夜夜躁狠狠久久av| 美女大奶头黄色视频| 在线天堂最新版资源| 国产探花极品一区二区| 午夜福利,免费看| 亚洲av日韩精品久久久久久密 | 桃花免费在线播放| 国产在线视频一区二区| 国产av精品麻豆| 麻豆av在线久日| 亚洲精品视频女| 看非洲黑人一级黄片| 成人国产av品久久久| 中文字幕制服av| 亚洲美女搞黄在线观看| 久久狼人影院| 午夜福利,免费看| 国产一区二区激情短视频 | 久久综合国产亚洲精品| 久久ye,这里只有精品| 在线观看免费高清a一片| 9191精品国产免费久久| 热re99久久国产66热| 久久久久国产精品人妻一区二区| 日韩 亚洲 欧美在线| 国产一级毛片在线| 国产乱人偷精品视频| 老熟女久久久| 欧美精品高潮呻吟av久久| 久久久精品免费免费高清| 亚洲成人国产一区在线观看 | 丝瓜视频免费看黄片| 伊人久久国产一区二区| 久久人人97超碰香蕉20202| 搡老岳熟女国产| 国产精品国产av在线观看| 19禁男女啪啪无遮挡网站| 男女边摸边吃奶| 国产一区二区三区av在线| 十分钟在线观看高清视频www| 青春草亚洲视频在线观看| 国产精品久久久久成人av| 婷婷色av中文字幕| 国产精品99久久99久久久不卡 | 男女下面插进去视频免费观看| 亚洲精品日韩在线中文字幕| 在线观看免费午夜福利视频| av又黄又爽大尺度在线免费看| 日韩av免费高清视频| 9色porny在线观看| 99久久99久久久精品蜜桃| 亚洲精品日本国产第一区| 免费看av在线观看网站| 黑人巨大精品欧美一区二区蜜桃| 国产日韩欧美在线精品| 男女床上黄色一级片免费看| 精品国产露脸久久av麻豆| 电影成人av| 99精品久久久久人妻精品| 亚洲综合色网址| 一级片'在线观看视频| 99久久综合免费| 精品亚洲乱码少妇综合久久| 国产av一区二区精品久久| av网站免费在线观看视频| 国产成人啪精品午夜网站| 亚洲精品成人av观看孕妇| 久久精品熟女亚洲av麻豆精品| 国产成人午夜福利电影在线观看| 另类亚洲欧美激情| 黑丝袜美女国产一区| 亚洲国产欧美一区二区综合| 观看av在线不卡| 国产精品女同一区二区软件| 亚洲精品国产一区二区精华液| 少妇的丰满在线观看| 黄片无遮挡物在线观看| 国产国语露脸激情在线看| 久久午夜综合久久蜜桃| 嫩草影院入口| 另类精品久久| 国产色婷婷99| videosex国产| 亚洲精品aⅴ在线观看| 国产精品偷伦视频观看了| 亚洲成国产人片在线观看| 国产精品女同一区二区软件| av不卡在线播放| 亚洲精品中文字幕在线视频| 久久毛片免费看一区二区三区| 这个男人来自地球电影免费观看 | 一区福利在线观看| 中文欧美无线码| 久久久精品94久久精品| 在线免费观看不下载黄p国产| 91精品三级在线观看| 99久久精品国产亚洲精品| 国产精品一区二区在线不卡| 蜜桃国产av成人99| 国产成人精品福利久久| 国产熟女午夜一区二区三区| 搡老乐熟女国产| 人妻人人澡人人爽人人| 久久精品国产a三级三级三级| 99re6热这里在线精品视频| 免费观看a级毛片全部| 在线观看三级黄色| www.精华液| 最近手机中文字幕大全| 晚上一个人看的免费电影| 日韩欧美一区视频在线观看| 欧美精品一区二区大全| 免费人妻精品一区二区三区视频| 高清av免费在线| 高清欧美精品videossex| 亚洲av成人不卡在线观看播放网 | 欧美国产精品一级二级三级| 国产黄色视频一区二区在线观看| 国产日韩欧美在线精品| 久久精品人人爽人人爽视色| av免费观看日本| 国产一区二区 视频在线| 欧美日韩精品网址| 精品人妻一区二区三区麻豆| 国产成人精品福利久久| 日本色播在线视频| 亚洲情色 制服丝袜| 国产精品久久久久成人av| 伊人久久国产一区二区| 久久精品国产亚洲av涩爱| 日韩人妻精品一区2区三区| 极品人妻少妇av视频| 欧美日韩视频高清一区二区三区二| 国产免费一区二区三区四区乱码| 欧美成人午夜精品| 午夜精品国产一区二区电影| 国产一区有黄有色的免费视频| 一级毛片黄色毛片免费观看视频| 精品久久久久久电影网| av又黄又爽大尺度在线免费看| 色播在线永久视频| 国产成人a∨麻豆精品| 国产日韩欧美视频二区| 国产免费又黄又爽又色| 久久国产精品大桥未久av| 精品国产乱码久久久久久小说| 最新在线观看一区二区三区 | 纵有疾风起免费观看全集完整版| 日日撸夜夜添| 午夜日韩欧美国产| 国产爽快片一区二区三区| 十八禁网站网址无遮挡| 丝袜人妻中文字幕| 国产精品三级大全| 一边摸一边抽搐一进一出视频| 免费少妇av软件| av.在线天堂| 一本—道久久a久久精品蜜桃钙片| 99久久综合免费| 亚洲美女搞黄在线观看| 国产成人精品福利久久| av免费观看日本| 午夜免费鲁丝| 免费看av在线观看网站| 欧美激情 高清一区二区三区| 亚洲av国产av综合av卡| 国产成人免费观看mmmm| 国产1区2区3区精品| 女人被躁到高潮嗷嗷叫费观| 亚洲av日韩精品久久久久久密 | 午夜福利,免费看| 久久精品亚洲av国产电影网| 欧美国产精品一级二级三级| 国产 精品1| 国产成人午夜福利电影在线观看| 又大又爽又粗| 久久国产亚洲av麻豆专区| 天天躁狠狠躁夜夜躁狠狠躁| 国产成人精品久久二区二区91 | xxxhd国产人妻xxx| 精品国产超薄肉色丝袜足j| 亚洲男人天堂网一区| 亚洲天堂av无毛| av在线播放精品| 丝袜在线中文字幕| 女性生殖器流出的白浆| 在线观看三级黄色| 丰满饥渴人妻一区二区三| 日韩,欧美,国产一区二区三区| 欧美日韩一级在线毛片| 成人漫画全彩无遮挡| 97精品久久久久久久久久精品| 久久亚洲国产成人精品v| 汤姆久久久久久久影院中文字幕| 久久久久精品国产欧美久久久 | 亚洲国产成人一精品久久久| 老司机影院毛片| 日本午夜av视频| 国产精品一区二区在线不卡| 一区二区三区激情视频| av视频免费观看在线观看| 亚洲国产欧美一区二区综合| www.精华液| 欧美成人午夜精品| 一本一本久久a久久精品综合妖精| 国产一区二区三区av在线| 免费观看性生交大片5| 午夜精品国产一区二区电影| www.av在线官网国产| 精品国产一区二区久久| 又黄又粗又硬又大视频| 久久国产精品男人的天堂亚洲| 永久免费av网站大全| 爱豆传媒免费全集在线观看| 黄色怎么调成土黄色| 欧美日韩亚洲高清精品| 免费女性裸体啪啪无遮挡网站| 精品一区在线观看国产| 悠悠久久av| 大香蕉久久网| 99香蕉大伊视频| av卡一久久| 极品少妇高潮喷水抽搐| 黄频高清免费视频| 欧美中文综合在线视频| 建设人人有责人人尽责人人享有的| 十八禁网站网址无遮挡| 久久久精品国产亚洲av高清涩受| 欧美日韩国产mv在线观看视频| 天天躁夜夜躁狠狠躁躁| 亚洲成av片中文字幕在线观看| 国产亚洲一区二区精品| 欧美黄色片欧美黄色片| 国产 一区精品| 久久国产亚洲av麻豆专区| 日本91视频免费播放| 国产精品 国内视频| 日韩大片免费观看网站| 综合色丁香网| 十八禁高潮呻吟视频| 国产熟女欧美一区二区| 大片电影免费在线观看免费| 免费黄色在线免费观看| 欧美日本中文国产一区发布| 午夜老司机福利片| 久久久久网色| 欧美黄色片欧美黄色片| 亚洲美女视频黄频| 久久久久网色| 人妻一区二区av| 久久精品人人爽人人爽视色| 日本91视频免费播放| 午夜日本视频在线| 在线观看免费高清a一片| 精品一区二区三卡| 久久精品亚洲av国产电影网| av国产久精品久网站免费入址| 久久精品aⅴ一区二区三区四区| 如日韩欧美国产精品一区二区三区| 日韩免费高清中文字幕av| 国产成人午夜福利电影在线观看| 精品国产一区二区久久| 免费黄色在线免费观看| 国产成人精品在线电影| 国产激情久久老熟女| 999久久久国产精品视频| 国产成人精品久久二区二区91 | 亚洲 欧美一区二区三区| 亚洲国产毛片av蜜桃av| 欧美日韩亚洲综合一区二区三区_| 一级毛片电影观看| 国产深夜福利视频在线观看| 久久久久久久久久久久大奶| 久久综合国产亚洲精品| 午夜福利视频在线观看免费| 国产精品偷伦视频观看了| 啦啦啦视频在线资源免费观看| 久久久国产欧美日韩av| 亚洲精品视频女| 天天躁日日躁夜夜躁夜夜| av视频免费观看在线观看| 国产精品一国产av| 又黄又粗又硬又大视频| 亚洲,欧美精品.| 日本wwww免费看| 在线免费观看不下载黄p国产| 久久精品人人爽人人爽视色| 国产精品 欧美亚洲| 亚洲av综合色区一区| 中文字幕另类日韩欧美亚洲嫩草| 天堂8中文在线网| 青春草视频在线免费观看| 日韩制服骚丝袜av| 卡戴珊不雅视频在线播放| 岛国毛片在线播放| 久久综合国产亚洲精品| 18禁国产床啪视频网站| 日韩人妻精品一区2区三区| 日韩欧美精品免费久久| 亚洲人成网站在线观看播放| 日本vs欧美在线观看视频| 亚洲三区欧美一区| 国产欧美亚洲国产| 最新在线观看一区二区三区 | 国产成人免费观看mmmm| 青春草国产在线视频| 免费女性裸体啪啪无遮挡网站| 天美传媒精品一区二区| 美女午夜性视频免费| bbb黄色大片| 日韩一区二区三区影片| 免费观看人在逋| 久久久久久久精品精品| 久久精品熟女亚洲av麻豆精品| 日韩不卡一区二区三区视频在线| 免费黄色在线免费观看| 国产有黄有色有爽视频| 最近中文字幕高清免费大全6| 成年动漫av网址| 日本vs欧美在线观看视频| 天堂俺去俺来也www色官网| 久久精品国产亚洲av高清一级| 国精品久久久久久国模美| 秋霞伦理黄片| 国产成人免费观看mmmm| 亚洲国产欧美日韩在线播放| 天天操日日干夜夜撸| 欧美日韩国产mv在线观看视频| 男女床上黄色一级片免费看| 成人三级做爰电影| 韩国精品一区二区三区| 街头女战士在线观看网站| 色婷婷久久久亚洲欧美| 欧美最新免费一区二区三区| 国产片内射在线| 国产又爽黄色视频| 精品一区二区三区四区五区乱码 | 18禁裸乳无遮挡动漫免费视频| 亚洲国产欧美日韩在线播放| 1024视频免费在线观看| 老司机影院成人| 免费观看av网站的网址| 大片免费播放器 马上看| 久久精品aⅴ一区二区三区四区| 性少妇av在线| 亚洲国产成人一精品久久久| 大香蕉久久成人网| 日韩 亚洲 欧美在线| 国产成人精品久久二区二区91 | 久久久久久久国产电影| 亚洲色图 男人天堂 中文字幕| 秋霞在线观看毛片| 国产精品 国内视频| 国产片特级美女逼逼视频| 国产伦人伦偷精品视频| 精品国产国语对白av| 国产高清不卡午夜福利| 国精品久久久久久国模美| 精品人妻熟女毛片av久久网站| 久久午夜综合久久蜜桃| 91精品三级在线观看| 操美女的视频在线观看| 妹子高潮喷水视频| 亚洲精品aⅴ在线观看| 久久ye,这里只有精品| 欧美精品高潮呻吟av久久| 最近最新中文字幕免费大全7| 嫩草影视91久久| 视频区图区小说| 亚洲专区中文字幕在线 | 亚洲综合精品二区| 天天添夜夜摸| 国产成人a∨麻豆精品| 日韩,欧美,国产一区二区三区| 久久ye,这里只有精品| 国产成人午夜福利电影在线观看| 男女边吃奶边做爰视频| 一个人免费看片子| 日本vs欧美在线观看视频| 久久久久久人人人人人| 如日韩欧美国产精品一区二区三区| 国产亚洲av高清不卡| 欧美在线一区亚洲| 老司机影院成人| 亚洲av日韩在线播放| 热99国产精品久久久久久7| 国产av码专区亚洲av| 女人爽到高潮嗷嗷叫在线视频| 久久精品人人爽人人爽视色| 在线观看免费高清a一片| 女性生殖器流出的白浆| 国产av国产精品国产| 日韩,欧美,国产一区二区三区| 国产成人av激情在线播放| 男女床上黄色一级片免费看| 精品少妇久久久久久888优播| 国产毛片在线视频| 久久热在线av| 亚洲精品一二三| 在线观看国产h片| 尾随美女入室| 亚洲欧洲精品一区二区精品久久久 | 少妇的丰满在线观看| 在线观看人妻少妇| 一本色道久久久久久精品综合| 国产成人系列免费观看| 亚洲精品乱久久久久久| 一级爰片在线观看| 啦啦啦在线观看免费高清www| 亚洲国产毛片av蜜桃av| av又黄又爽大尺度在线免费看| 天天影视国产精品| 国产亚洲欧美精品永久| 日韩精品免费视频一区二区三区| 亚洲精品国产一区二区精华液| 午夜福利视频在线观看免费| 中文字幕色久视频| 亚洲国产看品久久| 日本猛色少妇xxxxx猛交久久| 久久狼人影院| 久久久精品94久久精品| 欧美老熟妇乱子伦牲交| 校园人妻丝袜中文字幕|